SFI
IRWD icon

Susquehanna Fundamental Investments’s Ironwood Pharmaceuticals IRWD Stock Holding History

Susquehanna Fundamental Investments’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$1.04M Buy
82,415
+59,375
+258% +$681K 0.02% 826
2021
Q4 		$269K Sell
23,040
-21,885
-49% -$269K 0.01% 1150
2021
Q3 		$587K Buy
44,925
+7,238
+19% +$93.5K 0.01% 1123
2021
Q2 		$485K Buy
+37,687
New +$431K 0.01% 1183

Other funds holding IRWD

SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Susquehanna Fundamental Investments's IRWD Position: Q1 2022 in Review

Susquehanna Fundamental Investments increased its Ironwood Pharmaceuticals (IRWD) stake by 258% in Q1 2022, buying an estimated $681K and bringing the position to 82,415 shares worth $1.04M. The position accounts for 0.02% of the portfolio, ranked #826.

Susquehanna Fundamental Investments first reported a position in IRWD in Q2 2021 and has held it in 4 quarters since. 221 funds tracked by Wall St. Rank hold IRWD as of Q1 2022.

  • Susquehanna Fundamental Investments held 82,415 shares of Ironwood Pharmaceuticals worth $1.04M as of Q1 2022.
  • Susquehanna Fundamental Investments bought 59,375 Ironwood Pharmaceuticals shares in Q1 2022, an estimated $681K.
  • Ironwood Pharmaceuticals made up 0.02% of Susquehanna Fundamental Investments's portfolio in Q1 2022, its #826 holding.
  • Susquehanna Fundamental Investments first reported a position in Ironwood Pharmaceuticals in Q2 2021 and has held it in 4 quarters since.
  • 221 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2022.

Based on Susquehanna Fundamental Investments's 13F filing for Q1 2022, filed 16 May 2022.